Flossmoor, Illinois Clinical Trials

A listing of Flossmoor, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 66 clinical trials
Phase III Study Assessing the Efficacy Safety and Immunogenicity of SOK583A1 Versus Eylea in Patients With Neovascular Age-related Macular Degeneration

Purpose and rationale: To demonstrate similar efficacy, safety and immunogenicity of SOK583A1 and Eylea EU as per Eylea approved treatment regimen in patients with nAMD. The primary clinical question of interest is: Does SOK583A1 have similar efficacy as Eylea EU in terms of mean change in BCVA score in participants …

Sandoz Investigational Site
 (5.7 away) Contact site
  • 0 views
  • 17 Jul, 2021
  • +37 other locations
The Vesalio NeVa Stent Retriever Study for Treatment of Large Vessel Occlusion Strokes: CLEAR Study

A prospective, open label, single-arm 90-day study designed to assess the safety, performance and efficacy of thrombus removal in subjects presenting with acute ischemic stroke with the NeVa stent retrievers.

Community Hospital
 (9.4 away) Contact site
  • 0 views
  • 24 Jul, 2021
  • +6 other locations
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

vitamin d
fluorouracil
irinotecan
monoclonal antibodies
open biopsy
Ingalls Memorial Hospital
 (5.0 away) Contact site
  • 65 views
  • 27 Jul, 2021
  • +978 other locations
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

This is a study of tirzepatide in participants with obesity or overweight. The main purpose is to learn more about how tirzepatide maintains body weight loss. The study has two phases: a lead-in phase in which all participants take tirzepatide and a treatment phase in which participants will either continue …

dyslipidemia
body mass index
hypertension
cardiovascular disease
Healthcare Research Network - Chicago
 (0.2 away) Contact site
  • 9 views
  • 30 Jul, 2021
  • +76 other locations
Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder

The study's purpose its to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compulsive Disorder (OCD)

serotonin reuptake inhibitors
clomipramine
fluvoxamine
University of Chicago Department of Psychiatry & Behavioral Neuroscience
 (17.1 away) Contact site
  • 0 views
  • 18 Jul, 2021
  • +88 other locations
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer the CompassHER2 RD Trial

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted …

Ingalls Memorial Hospital
 (5.1 away) Contact site
  • 0 views
  • 26 Jul, 2021
  • +762 other locations
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical …

Ingalls Memorial Hospital
 (5.1 away) Contact site
  • 0 views
  • 27 Jul, 2021
  • +340 other locations
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well monoclonal antibodies work, either alone or in combination, against the virus that causes COVID-19. Study drug(s) will be given to participants with early symptoms of COVID-19. Samples will be taken from the back of the nose to determine how much …

Franciscan Health Hammond
 (9.8 away) Contact site
  • 0 views
  • 29 Jul, 2021
  • +166 other locations
Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

Unity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in Patients with Previously Treated Non-Hodgkin's Lymphoma

diffuse large b-cell lymphoma
mantle cell lymphoma
marginal zone lymphoma
hodgkin's disease
ibrutinib
TG Therapeutics Investigational Trial Site
 (5.0 away) Contact site
  • 0 views
  • 30 Jul, 2021
  • +203 other locations
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with stage IIa-IIIa cancer who have undergone mastectomy. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells that remain after surgery …

lobular carcinoma in situ
ductal carcinoma in situ
diabetes
lobular carcinoma
non-melanoma skin cancer
Loyola Center for Cancer Care and Research
 (9.8 away) Contact site
  • 335 views
  • 28 Jul, 2021
  • +911 other locations